Estrogen shows promise in warding off heart disease in young rats

December 20, 1999

COLUMBUS, Ohio -- Because of its effects in reducing health risks such as heart disease, many women start taking estrogen supplements when they reach menopause. Yet new evidence in animals suggests that treatment should start before menopause begins.

Supplemental estrogen prevented hypertension -- or abnormally high blood pressure -- in 3-month-old female rats with healthy hearts who had their ovaries removed, resulting in surgical menopause.

But 17-month-old rats who had received estrogen at the beginning of natural menopause -- and after hypertension had already begun -- did not reap the same benefit.

"There still isn't a consensus on supplemental estrogen's benefits to heart health during the post-menopausal years," said Judith Radin, co-author of the study and an associate professor of veterinary sciences at Ohio State University.

"But our findings suggest that estrogen supplementation may be important for a woman nearing or going through perimenopause." Perimenopause is the three-to-five year period before menopause when estrogen levels begin to decline.

The research appeared in a recent issue of the Journal of Molecular and Cellular Cardiology.

The researchers studied a strain of rats that develops hypertension at around 4 months of age. And when these rats reach menopause -- typically around 17 months of age -- their hearts start to enlarge. Women often experience a rise in blood pressure when they reach menopause.

The researchers were also interested in the role estrogen played in the prevention of congestive heart failure (CHF). In CHF, the heart loses its ability to pump blood.

Radin and her colleagues studied two groups of female rats: 17 3-month-old rats and 16 17-month-old rats. In the first group, 12 had had their ovaries removed, and half of those received supplemental estrogen. The ovaries were removed before the rats developed signs of hypertension. The rest of the rats neither received estrogen nor had their ovaries removed. In the second group, all rats had reached menopause naturally. Eight were given estrogen supplements, and the rest were given a placebo.

In the first group, some rats received 1.5 mg of estrogen via a time-release pellet implanted under the skin. The rest of the rats received an implanted placebo pellet. The researchers took each rat's blood pressure every four weeks. Pellets were replaced every 60 days for the duration of the study.

In comparison to the rats who had their ovaries removed without supplementation, the rats who had received supplemental estrogen had significantly lower body weights (176 grams vs. 295 grams). Just as in humans, higher body weights increase the risk of hypertension. The rats receiving estrogen also had lower systolic blood pressures (130 mmHg vs. 160 mmHg) at the end of the study.

The young rats who did not have their ovaries removed and did not receive estrogen did develop hypertension (systolic reading of 155 mmHg) and weighed an average of 210 grams.

In the older group, each rat had reached menopause naturally. At this point, estrogen levels had significantly declined. Also, each rat had been hypertensive for most of her life. Half (eight) of these rats received a 1.5 mg time-release estrogen pellet implant, while the other half received placebo implants. The researchers took blood pressure readings every four weeks. Pellets were replaced every 90 days for the duration of the experiment.

Estrogen supplements did not reduce blood pressure or prevent CHF in the 17-month-old rats who already suffered from hypertension. Results showed that in these menopausal rats, estrogen supplements did not increase survival time.

"The supplemental estrogen didn't give the menopausal rats any additional health benefits," Radin said. The presence of chronic, untreated hypertension probably outweighed any benefit of the estrogen therapy.

Support for this research came from a U.S. Public Health Service grant and from the Ohio Agricultural Research and Development Center.
-end-
Contact: Judith Radin, (614) 292-4266;
Radin.1@osu.edu
Written by Holly Wagner, (614) 292-8310;
Wagner.235@osu.edu

Ohio State University

Related Blood Pressure Articles from Brightsurf:

Children who take steroids at increased risk for diabetes, high blood pressure, blood clots
Children who take oral steroids to treat asthma or autoimmune diseases have an increased risk of diabetes, high blood pressure, and blood clots, according to Rutgers researchers.

High blood pressure treatment linked to less risk for drop in blood pressure upon standing
Treatment to lower blood pressure did not increase and may decrease the risk of extreme drops in blood pressure upon standing from a sitting position.

Changes in blood pressure control over 2 decades among US adults with high blood pressure
National survey data were used to examine how blood pressure control changed overall among U.S. adults with high blood pressure between 1999-2000 and 2017-2018 and by age, race, insurance type and access to health care.

Transient increase in blood pressure promotes some blood vessel growth
Blood vessels are the body's transportation system, carrying oxygen and nutrients to cells and whisking away waste.

Effect of reducing blood pressure medications on blood pressure control in older adults
Whether the amount of blood pressure medications taken by older adults could be reduced safely and without a significant change in short-term blood pressure control was the objective of this randomized clinical trial that included 534 adults 80 and older.

Brain blood flow sensor discovery could aid treatments for high blood pressure & dementia
A study led by researchers at UCL has discovered the mechanism that allows the brain to monitor its own blood supply, a finding in rats which may help to find new treatments for human conditions including hypertension (high blood pressure) and dementia.

Here's something that will raise your blood pressure
The apelin receptor (APJ) has been presumed to play an important role in the contraction of blood vessels involved in blood pressure regulation.

New strategy for treating high blood pressure
The key to treating blood pressure might lie in people who are 'resistant' to developing high blood pressure even when they eat high salt diets, shows new research published today in Experimental Physiology.

Arm cuff blood pressure measurements may fall short for predicting heart disease risk in some people with resistant high blood pressure
A measurement of central blood pressure in people with difficult-to-treat high blood pressure could help reduce risk of heart disease better than traditional arm cuff readings for some patients, according to preliminary research presented at the American Heart Association's Hypertension 2019 Scientific Sessions.

Heating pads may lower blood pressure in people with high blood pressure when lying down
In people with supine hypertension due to autonomic failure, a condition that increases blood pressure when lying down, overnight heat therapy significantly decreased systolic blood pressure compared to a placebo.

Read More: Blood Pressure News and Blood Pressure Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.